Category Archives: Pulse
Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 2 – The Pfizer case
Link to article
Posted in Pulse
Tagged Big pharma, Orphan drugs, Rare diseases
Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 1 – The Novartis case
Link to article
Posted in Pulse
Tagged Big pharma, Orphan drugs, Rare diseases